With new evidence suggesting Black and Hispanic populations were disproportionately affected by the pandemic, experts weigh in on the importance of vaccination and addressing health disparities
Supriya Munshaw, an expert in drug commercialization, discusses what factors went into the FDA approval of aducanumab, a drug known by the brand name Aduhelm
Standardizing demographic data reporting practices across the U.S. should be a national priority to confront the current and future pandemics, according to Hopkins expert Beth Blauer
Study suggests the declining use of the COVID-19 therapy at U.S. hospitals from November 2020 to February 2021 may have led to more than 29,000 excess COVID-19 deaths